Fund Holdings — Foresite Capital Management IV, LLC

Total Portfolio Value:
$123.80M
Total Bought:
$12.08M
Total Sold:
$11.24M
Net Transaction:
+$846.2K
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Pharvaris N.V.
COM
4,410,5814,410,5810$69.25M$77.63M62.70%+$8.38M
Maze Therapeutics, Inc.(MAZE)2,111,9192,111,9190$23.25M$25.91M20.93%+$2.66M
Lyell Immunopharma, Inc.(LYEL)0800,399+800,399$0$7.08M5.72%+$7.08M
Xenon Pharmaceuticals Inc.(XENE)0160,000+160,000$0$5.01M4.05%+$5.01M
Kura Oncology, Inc.(KURA)1,111,882816,882-295,000$7.34M$4.71M3.81%-$2.63M
Relay Therapeutics, Inc.(RLAY)1,000,0001,000,0000$2.62M$3.46M2.79%+$840.0K
Lyell Immunopharma, Inc.(LYEL)16,007,9990-16,007,999$8.61M$0—-$8.61M
Page 1 of 1
Foresite Capital Management IV, LLC — 13F Holdings — Q2 2025 | TickerTrail